DX-8951f in Treating Patients With Metastatic Stomach Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

exatecan mesylate

Trial Locations (6)

80218

Rocky Mountain Cancer Centers, Denver

90813

Pacific Shores Medical Group, Long Beach

75235-9154

Simmons Cancer Center - Dallas, Dallas

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

78229-3264

Cancer Therapy and Research Center, San Antonio

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00017212 - DX-8951f in Treating Patients With Metastatic Stomach Cancer | Biotech Hunter | Biotech Hunter